Seroquel XR in schizophrenia relapse prevention

Study identifier:NIS-NHU-SER-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Seroquel XR in schizophrenia relapse prevention

Medical condition

schizophrenia relapse prevention

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1600

Study type

Observational

Age

18 Years - 70 Years

Date

Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria